V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260012408 | 260007747 | null | null | Disease modification (D) | 2017-11-12 | 2017-12-06 | Rituximab | 2 | N | 260023562 | RITUXIMAB |
| 260012409 | 260007749 | 1.77 | 98 | Adjuvant (A) | 2015-05-01 | 2015-05-15 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 260023562 | BENDAMUSTINE + RITUXIMAB |
| 260012410 | 260017841 | 1.76 | 81.5 | Adjuvant (A) | 2014-11-28 | 2014-11-28 | BENDAMUSTINE + RITUXIMAB | N | N | 260023564 | BENDAMUSTINE + RITUXIMAB |
| 260012411 | 260007750 | 1.67 | 61.8 | Adjuvant (A) | 2013-07-15 | 2013-08-28 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260023566 | BENDAMUSTINE + RITUXIMAB |
| 260012412 | 260007750 | 1.8 | 50.4 | Curative (C) | 2017-04-01 | 2017-04-01 | BEP 3 day | 2 | N | 260023566 | BEP |
| 260012413 | 260017842 | 1.66 | 104.8 | Adjuvant (A) | 2017-06-30 | 2017-06-30 | Bendamustine+Rituximab(Sub Courses) | N | N | 260023577 | BENDAMUSTINE + RITUXIMAB |
| 260012414 | 260007751 | null | 73.6 | Not known (9) | 2014-09-17 | 2014-10-31 | BEP 3 day | N | N | 260023578 | BEP |
| 260012415 | 260013531 | 1.8 | 96 | Curative (C) | 2016-12-18 | 2016-12-21 | BEP 5 Day | 02 | N | 260023579 | BEP |
| 260012416 | 260013531 | 1.59 | 56.2 | Curative (C) | 2018-04-11 | 2018-04-17 | BEP 5 Day | N | N | 260023579 | BEP |
| 260012417 | 260017843 | 1.8 | 72 | Curative (C) | 2015-07-22 | 2015-07-28 | BEP 5 Day | 02 | N | 260023590 | BEP |
| 260012418 | 260016391 | 1.8 | 71.7 | Disease modification (D) | 2016-02-16 | 2016-03-06 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023590 | BENDAMUSTINE + RITUXIMAB |
| 260012419 | 260013534 | 1.64 | 77 | Curative (C) | 2016-11-07 | 2016-12-04 | BEP 3 day | 02 | N | 260023597 | BEP |
| 260012420 | 260007755 | 1.88 | 107 | Adjuvant (A) | 2015-07-29 | 2015-07-30 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023598 | BENDAMUSTINE + RITUXIMAB |
| 260012421 | 260013535 | 0 | 71.3 | Curative (C) | null | 2016-04-01 | BEP 5 Day | N | N | 260023599 | BEP |
| 260012422 | 260007756 | 1.78 | 75 | Not known (9) | 2016-12-05 | 2016-12-06 | BEP 5 Day | N | N | 260023601 | BEP |
| 260012423 | 260013537 | 1.75 | 77.3 | Adjuvant (A) | 2013-12-21 | 2014-03-29 | Bendamustine+Rituximab(Sub Courses) | 2 | N | 260023602 | BENDAMUSTINE + RITUXIMAB |
| 260012424 | 260016393 | 1.71 | 74.9 | Curative (C) | 2017-12-17 | 2018-01-22 | BEP 3 day | N | N | 260023607 | BEP |
| 260012425 | 260017845 | 1.84 | 82.2 | Adjuvant (A) | 2014-09-18 | 2014-12-07 | BENDAMUSTINE + RITUXIMAB | N | N | 260023608 | BENDAMUSTINE + RITUXIMAB |
| 260012426 | 260018587 | 1.58 | 64.3 | Curative (C) | 2018-07-08 | 2018-07-18 | BEP 5 Day | N | N | 260023609 | BEP |
| 260012427 | 260018988 | 1.63 | 188 | Disease modification (D) | 2017-11-10 | 2017-11-15 | Bendamustine+Rituximab(Sub Courses) | N | N | 260023610 | BENDAMUSTINE + RITUXIMAB |
| 260012428 | 260007758 | 1.74 | null | Adjuvant (A) | 2016-06-04 | 2016-10-07 | BEP 5 Day | N | null | 260023611 | BEP |
| 260012429 | 260007758 | null | null | Palliative (P) | 2016-11-20 | 2016-12-04 | Bendamustine+Rituximab(Sub Courses) | null | null | 260023611 | BENDAMUSTINE + RITUXIMAB |
| 260012430 | 260017846 | 1.46 | 73.8 | Curative (C) | 2014-07-22 | 2014-09-02 | BENDAMUSTINE + RITUXIMAB | N | N | 260023617 | BENDAMUSTINE + RITUXIMAB |
| 260012431 | 260007759 | 1.87 | 72.6 | Adjuvant (A) | 2017-11-16 | 2017-11-18 | BENDAMUSTINE + RITUXIMAB | N | N | 260023627 | BENDAMUSTINE + RITUXIMAB |
| 260012432 | 260016395 | 1.79 | null | Curative (C) | null | 2015-05-29 | BEP 3 day | N | null | 260023632 | BEP |
| 260012433 | 260018589 | null | 103 | Disease modification (D) | 2015-04-09 | 2015-04-13 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023634 | BENDAMUSTINE + RITUXIMAB |
| 260012434 | 260018589 | 1.55 | 71.7 | Neo-adjuvant (N) | 2015-02-15 | 2015-03-09 | BEP 3 day | 02 | N | 260023634 | BEP |
| 260012435 | 260007760 | 1.61 | 96.15 | Curative (C) | 2013-12-27 | 2014-01-14 | BEP 5 Day | N | null | 260023639 | BEP |
| 260012436 | 260013540 | 1.67 | 92.3 | Adjuvant (A) | null | 2014-04-16 | Bendamustine+Rituximab(Sub Courses) | N | N | 260023642 | BENDAMUSTINE + RITUXIMAB |
| 260012437 | 260013540 | 0 | 104.2 | Adjuvant (A) | 2018-12-29 | 2018-12-29 | Bendamustine+Rituximab (1st Course) | 02 | N | 260023642 | BENDAMUSTINE + RITUXIMAB |
| 260012438 | 260013540 | 1.57 | 57 | Adjuvant (A) | 2017-11-17 | 2017-11-19 | BEP 3 day | N | N | 260023642 | BEP |
| 260012439 | 260013540 | 1.6 | 74.55 | null | 2016-05-21 | 2016-05-26 | BEP 5 Day | N | N | 260023642 | BEP |
| 260012440 | 260013540 | 1.83 | 89.1 | Curative (C) | null | 2013-07-18 | BENDAMUSTINE + RITUXIMAB | N | N | 260023642 | BENDAMUSTINE + RITUXIMAB |
| 260012441 | 260007761 | 1.81 | 77 | Adjuvant (A) | null | 2017-10-28 | Bendamustine+Rituximab (1st Course) | Y | N | 260023652 | BENDAMUSTINE + RITUXIMAB |
| 260012442 | 260007761 | 1.58 | null | Adjuvant (A) | 2015-03-18 | 2015-04-06 | BENDAMUSTINE + RITUXIMAB | N | null | 260023652 | BENDAMUSTINE + RITUXIMAB |
| 260012443 | 260007762 | 1.78 | 50 | Curative (C) | 2013-04-23 | 2013-04-28 | BEP 5 Day | N | N | 260023657 | BEP |
| 260012444 | 260007763 | 1.8 | 94.5 | Curative (C) | 2017-06-28 | 2017-07-14 | BEP 3 day | N | N | 260023658 | BEP |
| 260012445 | 260007763 | 1.64 | 77.3 | Curative (C) | 2017-10-01 | 2017-11-19 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023658 | BENDAMUSTINE + RITUXIMAB |
| 260012446 | 260017849 | 1.6 | 76.2 | Adjuvant (A) | 2017-04-10 | 2017-04-12 | BEP 3 day | N | N | 260023663 | BEP |
| 260012447 | 260007765 | 1.9 | 61.8 | Adjuvant (A) | 2017-10-18 | 2017-11-25 | Bendamustine+Rituximab(Sub Courses) | N | N | 260023664 | BENDAMUSTINE + RITUXIMAB |
| 260012448 | 260013544 | 1.79 | 78.1 | Adjuvant (A) | 2015-02-22 | 2015-03-04 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 260023665 | BENDAMUSTINE + RITUXIMAB |
| 260012449 | 260007766 | 1.71 | 108.8 | Adjuvant (A) | 2016-04-01 | 2016-04-16 | BEP 5 Day | N | N | 260023665 | BEP |
| 260012450 | 260007766 | null | 108.299 | Adjuvant (A) | 2017-11-18 | 2018-02-06 | BEP 3 day | N | null | 260023665 | BEP |
| 260012451 | 260007766 | 1.81 | 63.2 | Adjuvant (A) | null | 2013-10-30 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023665 | BENDAMUSTINE + RITUXIMAB |
| 260012452 | 260007767 | 1.68 | 72.8 | Adjuvant (A) | 2014-06-20 | 2014-08-08 | BENDAMUSTINE + RITUXIMAB | N | N | 260023678 | BENDAMUSTINE + RITUXIMAB |
| 260012453 | 260007769 | null | 102.1 | Curative (C) | 2019-02-28 | 2019-03-23 | BEP 5 Day | N | N | 260023681 | BEP |
| 260012454 | 260013546 | 1.76 | 89.6 | Adjuvant (A) | 2012-12-20 | 2013-02-01 | BENDAMUSTINE + RITUXIMAB | N | N | 260023681 | BENDAMUSTINE + RITUXIMAB |
| 260012455 | 260013546 | 1.76 | 84.7 | Neo-adjuvant (N) | 2013-04-16 | 2013-06-17 | BEP 5 Day | N | N | 260023681 | BEP |
| 260012456 | 260019348 | 1.78 | 116.3 | Curative (C) | 2017-05-20 | 2017-06-25 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 260023690 | BENDAMUSTINE + RITUXIMAB |
| 260012457 | 260019348 | 1.8 | 74.3 | Adjuvant (A) | 2015-09-22 | 2015-09-29 | BENDAMUSTINE + RITUXIMAB | N | N | 260023690 | BENDAMUSTINE + RITUXIMAB |